Regulation of myocardial GPCRs by USP20 in normal and hypertrophied heart
Regulation of myocardial GPCRs by USP20 in normal and hypertrophied heart
批准号:
10427441
负责人:
SUDHA K SHENOY
金额:
$56.21万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-07-01 至 2025-06-30
关键词:
AddressAdrenergic ReceptorAffectAffinityAgonistAmericanApoptosisAutophagocytosisAutophagosomeBiomechanicsBlood PressureC57BL/6 MouseCardiacCardiac MyocytesCardiac developmentCardiomegalyCellular StressChronicClustered Regularly Interspaced Short Palindromic RepeatsComplexControl GroupsCouplingCyclic AMP-Dependent Protein KinasesDeubiquitinationDown-RegulationDrug ScreeningFibrosisFunctional disorderG-Protein-Coupled ReceptorsGTP-Binding ProteinsGenesHeartHeart HypertrophyHeart failureHumanHypertensionHypertrophyIsoproterenolKnock-in MouseKnockout MiceLabelLeadLeft Ventricular HypertrophyLeft Ventricular RemodelingLigandsLinkLysineMass Spectrum AnalysisMediatingMusMyocardialMyocardial dysfunctionMyocardiumPathologicPathway interactionsPatientsPhosphorylationPlayPolyubiquitinationProteinsReceptor ActivationRegulationResearchRoleSignal TransductionSignaling ProteinTestingTransducersUbiquitinationbeta-2 Adrenergic Receptorscardioprotectionconstrictiondesensitizationdrug discoveryexperimental studyheart functionhypertensivein vivomortalitynovelpressurepreventprotein expressionreceptorreceptor expressionresponsetraffickingubiquitin-specific protease
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Chronic pressure overload that leads to left ventricular hypertrophy (LVH) and adverse cardiac remodeling
is one of the leading causes of heart failure and affects millions of Americans. In addition to pathological
insults and biomechanical factors, neurohormonal pathways that involve coordinated signaling through β1 and
β2 adrenergic receptors (ARs) can play a major role in myocardial adaptation to pressure overload. The factors
that shift the myocardial response to pressure overload from adaptive to maladaptive LVH remain largely
obscure. Our research has focused on the regulation of βAR trafficking and signaling by
ubiquitination/deubiquitination mechanisms. We recently discovered that differential regulation of β1AR and
β2AR endocytic trafficking can be achieved by the deubiquitinase (DUB) called ubiquitin-specific protease-20
(USP20), which we found deubiquitinates both βARs. In response to the βAR agonist (-)isoproterenol (Iso),
USP20 is phosphorylated on Ser333 by protein kinase A (PKA); this phosphorylation inhibits USP20 DUB
activity toward the β2AR and regulates trafficking of the β2AR to autophagosomes. USP20 phosphorylation
occurs in vivo, as well: (1) USP20 phosphorylation is significantly elevated in failing human hearts when
compared with non-failing hearts and (2) pressure overload achieved by transverse aortic constriction (TAC)
triggers USP20 phosphorylation in cardiomyocytes of WT, but not β1AR KO mice. Accordingly, during LVH,
USP20 phosphorylation requires β1AR activation in the heart and may play a role in pathologic remodeling in
LVH and/or heart failure. We hypothesize that “USP20 and its phosphorylation status fine-tune βAR
signal transduction, endocytic trafficking and autophagy, thus impacting cardiac remodeling in LVH.”
We will test our hypotheses by addressing the following specific aims: (1) To determine the role of
cardiomyocyte-USP20 in the development of cardiac dysfunction, (2) To determine the regulation of
myocardial βAR signaling by USP20 Ser333 phosphorylation and (3) To determine the coordinated
roles of β1AR and USP20 in regulating ubiquitination status of the autophagy protein Beclin1 and its
effect in cardiomyocyte autophagy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of myocardial GPCRs by USP20 in normal and hypertrophied heart
-
批准号:10317884
-
项目类别:
-
资助金额:$56.21万
-
财政年份:2021
-
负责人:SUDHA K SHENOY
-
依托单位:
Regulation of myocardial GPCRs by USP20 in normal and hypertrophied heart
-
批准号:10630331
-
项目类别:
-
资助金额:$56.21万
-
财政年份:2021
-
负责人:SUDHA K SHENOY
-
依托单位:
E3 Ligases and Deubiquitinases in GPCR downregulation
-
批准号:7837166
-
项目类别:
-
资助金额:$23.76万
-
财政年份:2009
-
负责人:SUDHA K SHENOY
-
依托单位:
E3 Ligases and Deubiquitinases in GPCR Down Regulation
-
批准号:8280416
-
项目类别:
-
资助金额:$34.97万
-
财政年份:2005
-
负责人:SUDHA K SHENOY
-
依托单位:
E3 Ligases and Deubiquitinases in GPCR downregulation
-
批准号:7643479
-
项目类别:
-
资助金额:$25.89万
-
财政年份:2005
-
负责人:SUDHA K SHENOY
-
依托单位:
E3 Ligases and Deubiquitinases in GPCR downregulation
-
批准号:7100938
-
项目类别:
-
资助金额:$26.58万
-
财政年份:2005
-
负责人:SUDHA K SHENOY
-
依托单位:
E3 Ligases and Deubiquitinases in GPCR downregulation
-
批准号:7477764
-
项目类别:
-
资助金额:$25.89万
-
财政年份:2005
-
负责人:SUDHA K SHENOY
-
依托单位:
E3 Ligases and Deubiquitinases in GPCR downregulation
-
批准号:7269341
-
项目类别:
-
资助金额:$25.89万
-
财政年份:2005
-
负责人:SUDHA K SHENOY
-
依托单位:
E3 Ligases and Deubiquitinases in GPCR Down Regulation
-
批准号:7987494
-
项目类别:
-
资助金额:$35.33万
-
财政年份:2005
-
负责人:SUDHA K SHENOY
-
依托单位:
E3 Ligases and Deubiquitinases in GPCR Down Regulation
-
批准号:8688312
-
项目类别:
-
资助金额:$34.27万
-
财政年份:2005
-
负责人:SUDHA K SHENOY
-
依托单位:
E3 Ligases and Deubiquitinases in GPCR downregulation
-
批准号:6911172
-
项目类别:
-
资助金额:$27.13万
-
财政年份:2005
-
负责人:SUDHA K SHENOY
-
依托单位:
E3 Ligases and Deubiquitinases in GPCR Down Regulation
-
批准号:8495390
-
项目类别:
-
资助金额:$33.29万
-
财政年份:2005
-
负责人:SUDHA K SHENOY
-
依托单位:
海外基金